Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Preliminary results
Quarterly results
Director departure
Appointed director
CC transcript
|
|
Alexza Pharmaceuticals Inc. (ALXA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/16/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 01/16/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 03/31/2017 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
| 03/31/2017 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
| 03/31/2017 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
| 07/15/2016 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 07/08/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/08/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/08/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/05/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/05/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/05/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 07/01/2016 |
8-K
| Quarterly results |
| 06/24/2016 |
8-K
| Form 8-K - Current report |
| 06/22/2016 |
4
| Grupo Ferrer Internacional, S.A. (10% Owner) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Bought 19,465,714 shares
@ $0.9, valued at
$17.5M
|
|
| 06/21/2016 |
4
| Kamemoto Edwin S (EVP, R&D, Regulatory & Quality) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 9,112 shares
@ $0
Disposed/sold 125,000 options to buy
@ $1.08, valued at
$135k
Disposed/sold 35,000 options to buy
@ $1.95, valued at
$68.3k
Disposed/sold 15,000 options to buy
@ $3.47, valued at
$52.1k
Disposed/sold 5,000 options to buy
@ $3.47, valued at
$17.4k
Disposed/sold 43,750 options to buy
@ $4.42, valued at
$193.4k
Disposed/sold 24,000 options to buy
@ $4.57, valued at
$109.7k
Disposed/sold 9,999 options to buy
@ $15.3, valued at
$153k
|
|
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| TURNER JOSEPH L (Director) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|